Global mRNA Vaccine And Therapeutics Market Research Report 2023
This report aims to provide a comprehensive presentation of the global market for mRNA Vaccine And Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Vaccine And Therapeutics.
The mRNA Vaccine And Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global mRNA Vaccine And Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccine And Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Vaccine And Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The mRNA Vaccine And Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global mRNA Vaccine And Therapeutics market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Vaccine And Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
- Argos Therapeutics
- BioNTech
- CureVac
- eTheRNA
- Ethris
- In-Cell-Art
- Moderna Therapeutics
- Sangamo Therapeutics
- Tiba Biotechnology
- Translate Bio
- Infectious Disease
- Cancer
- Others
- Hospital
- Research Institual
- North America
- United States
- Canada
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of mRNA Vaccine And Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 REPORT OVERVIEW
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Infectious Disease
1.2.3 Cancer
1.2.4 Others
1.3 Market by Application
1.3.1 Global mRNA Vaccine And Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Research Institual
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global mRNA Vaccine And Therapeutics Market Perspective (2018-2029)
2.2 mRNA Vaccine And Therapeutics Growth Trends by Region
2.2.1 Global mRNA Vaccine And Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 mRNA Vaccine And Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 mRNA Vaccine And Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 mRNA Vaccine And Therapeutics Market Dynamics
2.3.1 mRNA Vaccine And Therapeutics Industry Trends
2.3.2 mRNA Vaccine And Therapeutics Market Drivers
2.3.3 mRNA Vaccine And Therapeutics Market Challenges
2.3.4 mRNA Vaccine And Therapeutics Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue
3.1.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue (2018-2023)
3.1.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global mRNA Vaccine And Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Vaccine And Therapeutics Revenue
3.4 Global mRNA Vaccine And Therapeutics Market Concentration Ratio
3.4.1 Global mRNA Vaccine And Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccine And Therapeutics Revenue in 2022
3.5 mRNA Vaccine And Therapeutics Key Players Head office and Area Served
3.6 Key Players mRNA Vaccine And Therapeutics Product Solution and Service
3.7 Date of Enter into mRNA Vaccine And Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MRNA VACCINE AND THERAPEUTICS BREAKDOWN DATA BY TYPE
4.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2024-2029)
5 MRNA VACCINE AND THERAPEUTICS BREAKDOWN DATA BY APPLICATION
5.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America mRNA Vaccine And Therapeutics Market Size (2018-2029)
6.2 North America mRNA Vaccine And Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America mRNA Vaccine And Therapeutics Market Size by Country (2018-2023)
6.4 North America mRNA Vaccine And Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe mRNA Vaccine And Therapeutics Market Size (2018-2029)
7.2 Europe mRNA Vaccine And Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe mRNA Vaccine And Therapeutics Market Size by Country (2018-2023)
7.4 Europe mRNA Vaccine And Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America mRNA Vaccine And Therapeutics Market Size (2018-2029)
9.2 Latin America mRNA Vaccine And Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America mRNA Vaccine And Therapeutics Market Size by Country (2018-2023)
9.4 Latin America mRNA Vaccine And Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Argos Therapeutics
11.1.1 Argos Therapeutics Company Detail
11.1.2 Argos Therapeutics Business Overview
11.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Introduction
11.1.4 Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.1.5 Argos Therapeutics Recent Development
11.2 BioNTech
11.2.1 BioNTech Company Detail
11.2.2 BioNTech Business Overview
11.2.3 BioNTech mRNA Vaccine And Therapeutics Introduction
11.2.4 BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.2.5 BioNTech Recent Development
11.3 CureVac
11.3.1 CureVac Company Detail
11.3.2 CureVac Business Overview
11.3.3 CureVac mRNA Vaccine And Therapeutics Introduction
11.3.4 CureVac Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.3.5 CureVac Recent Development
11.4 eTheRNA
11.4.1 eTheRNA Company Detail
11.4.2 eTheRNA Business Overview
11.4.3 eTheRNA mRNA Vaccine And Therapeutics Introduction
11.4.4 eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.4.5 eTheRNA Recent Development
11.5 Ethris
11.5.1 Ethris Company Detail
11.5.2 Ethris Business Overview
11.5.3 Ethris mRNA Vaccine And Therapeutics Introduction
11.5.4 Ethris Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.5.5 Ethris Recent Development
11.6 In-Cell-Art
11.6.1 In-Cell-Art Company Detail
11.6.2 In-Cell-Art Business Overview
11.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Introduction
11.6.4 In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.6.5 In-Cell-Art Recent Development
11.7 Moderna Therapeutics
11.7.1 Moderna Therapeutics Company Detail
11.7.2 Moderna Therapeutics Business Overview
11.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Introduction
11.7.4 Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.7.5 Moderna Therapeutics Recent Development
11.8 Sangamo Therapeutics
11.8.1 Sangamo Therapeutics Company Detail
11.8.2 Sangamo Therapeutics Business Overview
11.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Introduction
11.8.4 Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.8.5 Sangamo Therapeutics Recent Development
11.9 Tiba Biotechnology
11.9.1 Tiba Biotechnology Company Detail
11.9.2 Tiba Biotechnology Business Overview
11.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Introduction
11.9.4 Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.9.5 Tiba Biotechnology Recent Development
11.10 Translate Bio
11.10.1 Translate Bio Company Detail
11.10.2 Translate Bio Business Overview
11.10.3 Translate Bio mRNA Vaccine And Therapeutics Introduction
11.10.4 Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.10.5 Translate Bio Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Infectious Disease
1.2.3 Cancer
1.2.4 Others
1.3 Market by Application
1.3.1 Global mRNA Vaccine And Therapeutics Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Research Institual
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 GLOBAL GROWTH TRENDS
2.1 Global mRNA Vaccine And Therapeutics Market Perspective (2018-2029)
2.2 mRNA Vaccine And Therapeutics Growth Trends by Region
2.2.1 Global mRNA Vaccine And Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 mRNA Vaccine And Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 mRNA Vaccine And Therapeutics Forecasted Market Size by Region (2024-2029)
2.3 mRNA Vaccine And Therapeutics Market Dynamics
2.3.1 mRNA Vaccine And Therapeutics Industry Trends
2.3.2 mRNA Vaccine And Therapeutics Market Drivers
2.3.3 mRNA Vaccine And Therapeutics Market Challenges
2.3.4 mRNA Vaccine And Therapeutics Market Restraints
3 COMPETITION LANDSCAPE BY KEY PLAYERS
3.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue
3.1.1 Global Top mRNA Vaccine And Therapeutics Players by Revenue (2018-2023)
3.1.2 Global mRNA Vaccine And Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global mRNA Vaccine And Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by mRNA Vaccine And Therapeutics Revenue
3.4 Global mRNA Vaccine And Therapeutics Market Concentration Ratio
3.4.1 Global mRNA Vaccine And Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by mRNA Vaccine And Therapeutics Revenue in 2022
3.5 mRNA Vaccine And Therapeutics Key Players Head office and Area Served
3.6 Key Players mRNA Vaccine And Therapeutics Product Solution and Service
3.7 Date of Enter into mRNA Vaccine And Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MRNA VACCINE AND THERAPEUTICS BREAKDOWN DATA BY TYPE
4.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2024-2029)
5 MRNA VACCINE AND THERAPEUTICS BREAKDOWN DATA BY APPLICATION
5.1 Global mRNA Vaccine And Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2024-2029)
6 NORTH AMERICA
6.1 North America mRNA Vaccine And Therapeutics Market Size (2018-2029)
6.2 North America mRNA Vaccine And Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America mRNA Vaccine And Therapeutics Market Size by Country (2018-2023)
6.4 North America mRNA Vaccine And Therapeutics Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 EUROPE
7.1 Europe mRNA Vaccine And Therapeutics Market Size (2018-2029)
7.2 Europe mRNA Vaccine And Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe mRNA Vaccine And Therapeutics Market Size by Country (2018-2023)
7.4 Europe mRNA Vaccine And Therapeutics Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 ASIA-PACIFIC
8.1 Asia-Pacific mRNA Vaccine And Therapeutics Market Size (2018-2029)
8.2 Asia-Pacific mRNA Vaccine And Therapeutics Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 LATIN AMERICA
9.1 Latin America mRNA Vaccine And Therapeutics Market Size (2018-2029)
9.2 Latin America mRNA Vaccine And Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America mRNA Vaccine And Therapeutics Market Size by Country (2018-2023)
9.4 Latin America mRNA Vaccine And Therapeutics Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa mRNA Vaccine And Therapeutics Market Size (2018-2029)
10.2 Middle East & Africa mRNA Vaccine And Therapeutics Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 KEY PLAYERS PROFILES
11.1 Argos Therapeutics
11.1.1 Argos Therapeutics Company Detail
11.1.2 Argos Therapeutics Business Overview
11.1.3 Argos Therapeutics mRNA Vaccine And Therapeutics Introduction
11.1.4 Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.1.5 Argos Therapeutics Recent Development
11.2 BioNTech
11.2.1 BioNTech Company Detail
11.2.2 BioNTech Business Overview
11.2.3 BioNTech mRNA Vaccine And Therapeutics Introduction
11.2.4 BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.2.5 BioNTech Recent Development
11.3 CureVac
11.3.1 CureVac Company Detail
11.3.2 CureVac Business Overview
11.3.3 CureVac mRNA Vaccine And Therapeutics Introduction
11.3.4 CureVac Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.3.5 CureVac Recent Development
11.4 eTheRNA
11.4.1 eTheRNA Company Detail
11.4.2 eTheRNA Business Overview
11.4.3 eTheRNA mRNA Vaccine And Therapeutics Introduction
11.4.4 eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.4.5 eTheRNA Recent Development
11.5 Ethris
11.5.1 Ethris Company Detail
11.5.2 Ethris Business Overview
11.5.3 Ethris mRNA Vaccine And Therapeutics Introduction
11.5.4 Ethris Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.5.5 Ethris Recent Development
11.6 In-Cell-Art
11.6.1 In-Cell-Art Company Detail
11.6.2 In-Cell-Art Business Overview
11.6.3 In-Cell-Art mRNA Vaccine And Therapeutics Introduction
11.6.4 In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.6.5 In-Cell-Art Recent Development
11.7 Moderna Therapeutics
11.7.1 Moderna Therapeutics Company Detail
11.7.2 Moderna Therapeutics Business Overview
11.7.3 Moderna Therapeutics mRNA Vaccine And Therapeutics Introduction
11.7.4 Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.7.5 Moderna Therapeutics Recent Development
11.8 Sangamo Therapeutics
11.8.1 Sangamo Therapeutics Company Detail
11.8.2 Sangamo Therapeutics Business Overview
11.8.3 Sangamo Therapeutics mRNA Vaccine And Therapeutics Introduction
11.8.4 Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.8.5 Sangamo Therapeutics Recent Development
11.9 Tiba Biotechnology
11.9.1 Tiba Biotechnology Company Detail
11.9.2 Tiba Biotechnology Business Overview
11.9.3 Tiba Biotechnology mRNA Vaccine And Therapeutics Introduction
11.9.4 Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.9.5 Tiba Biotechnology Recent Development
11.10 Translate Bio
11.10.1 Translate Bio Company Detail
11.10.2 Translate Bio Business Overview
11.10.3 Translate Bio mRNA Vaccine And Therapeutics Introduction
11.10.4 Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2018-2023)
11.10.5 Translate Bio Recent Development
12 ANALYST'S VIEWPOINTS/CONCLUSIONS
13 APPENDIX
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
LIST OF TABLES
Table 1. Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Infectious Disease
Table 3. Key Players of Cancer
Table 4. Key Players of Others
Table 5. Global mRNA Vaccine And Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global mRNA Vaccine And Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global mRNA Vaccine And Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global mRNA Vaccine And Therapeutics Market Share by Region (2018-2023)
Table 9. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global mRNA Vaccine And Therapeutics Market Share by Region (2024-2029)
Table 11. mRNA Vaccine And Therapeutics Market Trends
Table 12. mRNA Vaccine And Therapeutics Market Drivers
Table 13. mRNA Vaccine And Therapeutics Market Challenges
Table 14. mRNA Vaccine And Therapeutics Market Restraints
Table 15. Global mRNA Vaccine And Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global mRNA Vaccine And Therapeutics Market Share by Players (2018-2023)
Table 17. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine And Therapeutics as of 2022)
Table 18. Ranking of Global Top mRNA Vaccine And Therapeutics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by mRNA Vaccine And Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players mRNA Vaccine And Therapeutics Product Solution and Service
Table 22. Date of Enter into mRNA Vaccine And Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global mRNA Vaccine And Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2024-2029)
Table 28. Global mRNA Vaccine And Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2018-2023)
Table 30. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2024-2029)
Table 32. North America mRNA Vaccine And Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America mRNA Vaccine And Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America mRNA Vaccine And Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe mRNA Vaccine And Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe mRNA Vaccine And Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe mRNA Vaccine And Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific mRNA Vaccine And Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America mRNA Vaccine And Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America mRNA Vaccine And Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America mRNA Vaccine And Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa mRNA Vaccine And Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 47. Argos Therapeutics Company Detail
Table 48. Argos Therapeutics Business Overview
Table 49. Argos Therapeutics mRNA Vaccine And Therapeutics Product
Table 50. Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 51. Argos Therapeutics Recent Development
Table 52. BioNTech Company Detail
Table 53. BioNTech Business Overview
Table 54. BioNTech mRNA Vaccine And Therapeutics Product
Table 55. BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 56. BioNTech Recent Development
Table 57. CureVac Company Detail
Table 58. CureVac Business Overview
Table 59. CureVac mRNA Vaccine And Therapeutics Product
Table 60. CureVac Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 61. CureVac Recent Development
Table 62. eTheRNA Company Detail
Table 63. eTheRNA Business Overview
Table 64. eTheRNA mRNA Vaccine And Therapeutics Product
Table 65. eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 66. eTheRNA Recent Development
Table 67. Ethris Company Detail
Table 68. Ethris Business Overview
Table 69. Ethris mRNA Vaccine And Therapeutics Product
Table 70. Ethris Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 71. Ethris Recent Development
Table 72. In-Cell-Art Company Detail
Table 73. In-Cell-Art Business Overview
Table 74. In-Cell-Art mRNA Vaccine And Therapeutics Product
Table 75. In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 76. In-Cell-Art Recent Development
Table 77. Moderna Therapeutics Company Detail
Table 78. Moderna Therapeutics Business Overview
Table 79. Moderna Therapeutics mRNA Vaccine And Therapeutics Product
Table 80. Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 81. Moderna Therapeutics Recent Development
Table 82. Sangamo Therapeutics Company Detail
Table 83. Sangamo Therapeutics Business Overview
Table 84. Sangamo Therapeutics mRNA Vaccine And Therapeutics Product
Table 85. Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 86. Sangamo Therapeutics Recent Development
Table 87. Tiba Biotechnology Company Detail
Table 88. Tiba Biotechnology Business Overview
Table 89. Tiba Biotechnology mRNA Vaccine And Therapeutics Product
Table 90. Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 91. Tiba Biotechnology Recent Development
Table 92. Translate Bio Company Detail
Table 93. Translate Bio Business Overview
Table 94. Translate Bio mRNA Vaccine And Therapeutics Product
Table 95. Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 96. Translate Bio Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 1. Global mRNA Vaccine And Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Infectious Disease
Table 3. Key Players of Cancer
Table 4. Key Players of Others
Table 5. Global mRNA Vaccine And Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global mRNA Vaccine And Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 7. Global mRNA Vaccine And Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 8. Global mRNA Vaccine And Therapeutics Market Share by Region (2018-2023)
Table 9. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 10. Global mRNA Vaccine And Therapeutics Market Share by Region (2024-2029)
Table 11. mRNA Vaccine And Therapeutics Market Trends
Table 12. mRNA Vaccine And Therapeutics Market Drivers
Table 13. mRNA Vaccine And Therapeutics Market Challenges
Table 14. mRNA Vaccine And Therapeutics Market Restraints
Table 15. Global mRNA Vaccine And Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 16. Global mRNA Vaccine And Therapeutics Market Share by Players (2018-2023)
Table 17. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine And Therapeutics as of 2022)
Table 18. Ranking of Global Top mRNA Vaccine And Therapeutics Companies by Revenue (US$ Million) in 2022
Table 19. Global 5 Largest Players Market Share by mRNA Vaccine And Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players mRNA Vaccine And Therapeutics Product Solution and Service
Table 22. Date of Enter into mRNA Vaccine And Therapeutics Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global mRNA Vaccine And Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 25. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2018-2023)
Table 26. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 27. Global mRNA Vaccine And Therapeutics Revenue Market Share by Type (2024-2029)
Table 28. Global mRNA Vaccine And Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 29. Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2018-2023)
Table 30. Global mRNA Vaccine And Therapeutics Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 31. Global mRNA Vaccine And Therapeutics Revenue Market Share by Application (2024-2029)
Table 32. North America mRNA Vaccine And Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 33. North America mRNA Vaccine And Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 34. North America mRNA Vaccine And Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 35. Europe mRNA Vaccine And Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. Europe mRNA Vaccine And Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 37. Europe mRNA Vaccine And Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 38. Asia-Pacific mRNA Vaccine And Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 39. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 40. Asia-Pacific mRNA Vaccine And Therapeutics Market Size by Region (2024-2029) & (US$ Million)
Table 41. Latin America mRNA Vaccine And Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 42. Latin America mRNA Vaccine And Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 43. Latin America mRNA Vaccine And Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 44. Middle East & Africa mRNA Vaccine And Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 45. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 46. Middle East & Africa mRNA Vaccine And Therapeutics Market Size by Country (2024-2029) & (US$ Million)
Table 47. Argos Therapeutics Company Detail
Table 48. Argos Therapeutics Business Overview
Table 49. Argos Therapeutics mRNA Vaccine And Therapeutics Product
Table 50. Argos Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 51. Argos Therapeutics Recent Development
Table 52. BioNTech Company Detail
Table 53. BioNTech Business Overview
Table 54. BioNTech mRNA Vaccine And Therapeutics Product
Table 55. BioNTech Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 56. BioNTech Recent Development
Table 57. CureVac Company Detail
Table 58. CureVac Business Overview
Table 59. CureVac mRNA Vaccine And Therapeutics Product
Table 60. CureVac Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 61. CureVac Recent Development
Table 62. eTheRNA Company Detail
Table 63. eTheRNA Business Overview
Table 64. eTheRNA mRNA Vaccine And Therapeutics Product
Table 65. eTheRNA Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 66. eTheRNA Recent Development
Table 67. Ethris Company Detail
Table 68. Ethris Business Overview
Table 69. Ethris mRNA Vaccine And Therapeutics Product
Table 70. Ethris Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 71. Ethris Recent Development
Table 72. In-Cell-Art Company Detail
Table 73. In-Cell-Art Business Overview
Table 74. In-Cell-Art mRNA Vaccine And Therapeutics Product
Table 75. In-Cell-Art Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 76. In-Cell-Art Recent Development
Table 77. Moderna Therapeutics Company Detail
Table 78. Moderna Therapeutics Business Overview
Table 79. Moderna Therapeutics mRNA Vaccine And Therapeutics Product
Table 80. Moderna Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 81. Moderna Therapeutics Recent Development
Table 82. Sangamo Therapeutics Company Detail
Table 83. Sangamo Therapeutics Business Overview
Table 84. Sangamo Therapeutics mRNA Vaccine And Therapeutics Product
Table 85. Sangamo Therapeutics Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 86. Sangamo Therapeutics Recent Development
Table 87. Tiba Biotechnology Company Detail
Table 88. Tiba Biotechnology Business Overview
Table 89. Tiba Biotechnology mRNA Vaccine And Therapeutics Product
Table 90. Tiba Biotechnology Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 91. Tiba Biotechnology Recent Development
Table 92. Translate Bio Company Detail
Table 93. Translate Bio Business Overview
Table 94. Translate Bio mRNA Vaccine And Therapeutics Product
Table 95. Translate Bio Revenue in mRNA Vaccine And Therapeutics Business (2018-2023) & (US$ Million)
Table 96. Translate Bio Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Global mRNA Vaccine And Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global mRNA Vaccine And Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Infectious Disease Features
Figure 4. Cancer Features
Figure 5. Others Features
Figure 6. Global mRNA Vaccine And Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global mRNA Vaccine And Therapeutics Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Research Institual Case Studies
Figure 10. mRNA Vaccine And Therapeutics Report Years Considered
Figure 11. Global mRNA Vaccine And Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global mRNA Vaccine And Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global mRNA Vaccine And Therapeutics Market Share by Region: 2022 VS 2029
Figure 14. Global mRNA Vaccine And Therapeutics Market Share by Players in 2022
Figure 15. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine And Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by mRNA Vaccine And Therapeutics Revenue in 2022
Figure 17. North America mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America mRNA Vaccine And Therapeutics Market Share by Country (2018-2029)
Figure 19. United States mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe mRNA Vaccine And Therapeutics Market Share by Country (2018-2029)
Figure 23. Germany mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific mRNA Vaccine And Therapeutics Market Share by Region (2018-2029)
Figure 31. China mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America mRNA Vaccine And Therapeutics Market Share by Country (2018-2029)
Figure 39. Mexico mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa mRNA Vaccine And Therapeutics Market Share by Country (2018-2029)
Figure 43. Turkey mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Argos Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 46. BioNTech Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 47. CureVac Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 48. eTheRNA Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 49. Ethris Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 50. In-Cell-Art Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 51. Moderna Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 52. Sangamo Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 53. Tiba Biotechnology Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 54. Translate Bio Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
Figure 1. Global mRNA Vaccine And Therapeutics Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global mRNA Vaccine And Therapeutics Market Share by Type: 2022 VS 2029
Figure 3. Infectious Disease Features
Figure 4. Cancer Features
Figure 5. Others Features
Figure 6. Global mRNA Vaccine And Therapeutics Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 7. Global mRNA Vaccine And Therapeutics Market Share by Application: 2022 VS 2029
Figure 8. Hospital Case Studies
Figure 9. Research Institual Case Studies
Figure 10. mRNA Vaccine And Therapeutics Report Years Considered
Figure 11. Global mRNA Vaccine And Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global mRNA Vaccine And Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global mRNA Vaccine And Therapeutics Market Share by Region: 2022 VS 2029
Figure 14. Global mRNA Vaccine And Therapeutics Market Share by Players in 2022
Figure 15. Global Top mRNA Vaccine And Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Vaccine And Therapeutics as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by mRNA Vaccine And Therapeutics Revenue in 2022
Figure 17. North America mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America mRNA Vaccine And Therapeutics Market Share by Country (2018-2029)
Figure 19. United States mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe mRNA Vaccine And Therapeutics Market Share by Country (2018-2029)
Figure 23. Germany mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific mRNA Vaccine And Therapeutics Market Share by Region (2018-2029)
Figure 31. China mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America mRNA Vaccine And Therapeutics Market Share by Country (2018-2029)
Figure 39. Mexico mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa mRNA Vaccine And Therapeutics Market Share by Country (2018-2029)
Figure 43. Turkey mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia mRNA Vaccine And Therapeutics Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Argos Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 46. BioNTech Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 47. CureVac Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 48. eTheRNA Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 49. Ethris Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 50. In-Cell-Art Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 51. Moderna Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 52. Sangamo Therapeutics Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 53. Tiba Biotechnology Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 54. Translate Bio Revenue Growth Rate in mRNA Vaccine And Therapeutics Business (2018-2023)
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed
